Quality of life in patients with metastatic colorectal cancer receiving maintenance therapy after first-line inductive treatment: A quality of life sub-analysis of the AIO KRK 0207 phase III trial. 7. Juni 2016 Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H.-J., Hinke, A., Al-Batran, S.-E., Arnold, D., 2016. Ann Oncol 27(6), 149–206, 557P. doi:10.1093/annonc/mdw370.105 Abstract Quality of Life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: A preplanned analysis of the phase III AIO KRK 0207 trial. Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C.A., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach,… Weiterlesen Clinical Outcome of Targeted Therapy with Gefitinib in Metastatic NSCLC Depending on the Type of EGFR Mutation: A REASON Subgroup Analysis by Exon. Schuette, W., Dietel, M., Thomas, M., Eberhardt, W., Zirrgiebel, U., Radke, S., Schirmacher, P., 2016. Oncol Res Treat, 39 (suppl 1), (ID 0341) 120. doi:10.1159/000444354… Weiterlesen